**Specifications Table**TableSubject area*Biology*More specific subject area*Gene regulation and TFBS*Type of data*MatInspector data, figures and table*How data was acquired*In silico analysis of IRS-2 promoter sequence using Genomatix MatInspector software, ChIP assay, qRT-PCR*Data format*Raw Excel spreadsheet (.xls), filtered and analysed data*Experimental factors*Isolation of human GCs from the follicular fluid aspirates obtained after IVF treatment, grown in culture and FSH treated. Precipitation of protein--DNA complexes with anti-SP1 antibody and PCR*Experimental features*Analysis of known TFBS on IRS-2 promoter using MatInspector software, filtering the TFs that are regulated by FSH, validation of the induction of SP1 binding to IRS-2 gene promoter by FSH in human GCs by ChIP assay*Data source location*Delhi, India*Data accessibility*Data are provided with this article.*

**Value of the data**•IRS-2 protein is an important signaling component in the regulation of metabolism in human and other organisms. However, specific transcription regulation of IRS-2 has not yet been characterized completely in the existing literature.•This data exhibits all TFBS and the corresponding TFs that may bind human IRS-2 promoter.•FSH stimulated TFs and activation of human IRS-2 promoter.•The data provided in this paper would be extremely relevant for further analysis of the regulation of IRS-2 interactions especially related to cancer progression.

1. Data {#s0005}
=======

In order to identify the TF responsible for the activation of IRS-2 promoter activity downstream FSH, all TFBS in the IRS-2 promoter region [@bib3] were explored using the Genomatix MatInspector software ([Fig. 1](#f0005){ref-type="fig"}) followed by a search for TFs that are reported to be transcriptional activators of FSH ([Table 1](#t0005){ref-type="table"}, [Supplementary material](#s0035){ref-type="sec"}). The data also shows SP1 as a potential key TF downstream of FSH in human GCs as it has SP1 binding sites with a very high similarity (Core similarity=1) ([Table 2](#t0010){ref-type="table"}). The increased binding of SP1 to IRS-2 promoter by FSH in human GCs was validated by ChIP assay ([Fig. 2](#f0010){ref-type="fig"}). Here, we have identified putative TFBS in the IRS-2 promoter region and data thereof was subjected to IRS-2--protein interaction analysis to emphasize the importance of this data. Unweighted binary interactions were analyzed for TF regulatory genes in IRS-2 network using Cytoscape software tool and R-code ([Supplementary material](#s0035){ref-type="sec"})[Fig. 3](#f0015){ref-type="fig"}.

2. Experimental design-materials and methods {#s0010}
============================================

2.1. Transcription factor binding sites analysis {#s0015}
------------------------------------------------

We carried out an in-depth computational analysis of the transcription binding sites on human IRS-2 promoter to identify the potential TFs that are responsible for FSH mediated regulation of IRS-2 expression in human GCs. Human IRS-2 promoter sequence [@bib3] was analyzed for putative TFBS using MatInspector software version 8.1, Matrix Library 9.1 from the Genomatix suite v3.4 [@bib1]. The parameters for comparing the binding sites with data base were set at matrix similarity and core similarity 0.85 (maximum 1.00) ([Supplementary material](#s0035){ref-type="sec"}). TFBS in the IRS-2 promoter region were explored for IRS-2--protein interactions using open-access database [@bib4] for experimentally verified human transcriptional regulation interactions (HTRIdb) ([Supplementary material](#s0035){ref-type="sec"}).

2.2. Cell culture {#s0020}
-----------------

Human GCs were isolated from the follicular fluid aspirates obtained after IVF treatment of subjects as described earlier [@bib5]. Briefly, the follicular fluid was centrifuged at 350×g for 15 min to pellet follicular cells and the GCs were isolated on Percoll gradient. The cells were seeded in DMEM containing 5% FBS and supplemented with 1x antibiotic antimycotic solution in multiwell plates at 37 °C in 5% CO~2~.

2.3. Chromatin Immunoprecipitation (ChIP) and reverse-transcription quantitative PCR (qRT-PCR) {#s0025}
----------------------------------------------------------------------------------------------

Cells were serum starved and left either in the basal condition or with FSH (25 ng/mL) for 2 h. ChIP assay was performed as described earlier [@bib6], [@bib7]. Briefly, cells were fixed with 1% formaldehyde, quenched with 0.125 M glycine and washed with cold PBS. After cell lysis, protein--DNA complexes were incubated with 2 μg of anti-SP1 and 2 μg non-specific IgG (normal rabbit IgG, Santa Cruz) antibodies and protein G agarose. 50 μl of cell lysate was used as input control. Protein--DNA complexes were released from the antibodies with elution buffer. After RNase A treatment, each sample was decrosslinked at 67 °C overnight and DNA was purified using chromatin IP DNA purification kit (Active Motif, Carlsbad, CA) and then subjected to semi-quantitative PCR analysis with specific primers for SP1 binding site on promoter of IRS-2 gene. Primer sequences for IRS-2 promoter were 5′-ACAAGCCGCTGATTAATGAGGC-3′ and 5′-TGACTCGGCGTTACGC AGGCAC-3′. Relative real-time qPCR was performed on Applied Biosystems 7500 Fast Real Time PCR System using a Power SYBR® Green PCR Master Mix. PCR amplified products were separated on 1.5% agarose gel in TAE buffer. The quantity of mRNA was calculated based on the cycle threshold (Ct) values which were normalized to the expression of the reference gene (β2M), which served as internal control. Data are expressed as % input after normalizing the Ct values obtained from SP1 antibody treated samples with the Ct values from input DNA. All experiments were performed in triplicates.

Appendix A. Supplementary material {#s0035}
==================================

Supplementary material

Supplementary material

We are thankful to Avijit Podder and Dr. N. Lata for the analysis of IRS-2-protein interactions. This work was supported by research Grant (Ref. no. BT/PR5379/MED/14/631/2004; BT/PR8330/AAQ/01/313/2006) from the Department of Biotechnology (DBT), Government of India, New Delhi, India to RS.

Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.dib.2015.12.001](http://dx.doi.org/10.1016/j.dib.2015.12.001){#ir0005}.

![Identification of putative transcription factor-binding sites in the IRS-2 promoter region using Genomatix MatInspector software.](gr1){#f0005}

![FSH increases SP1 binding to IRS-2 promoter in human granulosa cells. ChIP assay was performed for verification of SP1 binding to IRS-2 promoter. Input reflects the relative amounts of sonicated DNA fragments before immunoprecipitations. (A) The relative amounts of IRS-2 promoter DNA fragments were determined with semi-quantitative PCR by separating the amplified product on 1.5% agarose gel. (B) The relative amounts of IRS-2 promoter DNA fragments were determined with qRT-PCR. Data are expressed as % input after normalizing the Ct values obtained from SP1 antibody treated samples with the Ct values from input DNA. Values presented are mean±SD from 3 independent experiments (*n*=3). \**P*\<0.05 vs. untreated. − IgG as negative control; + SP1 Antibody; i Input (Total sonicated DNA) as positive control.](gr2){#f0010}

![TF regulatory gene network for IRS-2.](gr3){#f0015}

###### 

Putative transcription factor binding sites in IRS-2 promoter region with match ≥15.

Table 1.

  **Matrix family**   **Matrix information**                                               **Match total**
  ------------------- -------------------------------------------------------------------- -----------------
  ZF02                Zinc finger with KRAB and SCAN domains 3                             88
  ZF5F                Zinc finger/POZ domain transcription factor                          73
  KLFS                Kruppel-like factor 7 (ubiquitous, UKLF)                             70
  E2FF                E2F transcription factor 1                                           69
  PLAG                Pleomorphic adenoma gene                                             56
  MZF1                Myeloid zinc finger protein MZF1                                     50
  TF2B                Transcription factor II B (TFIIB) recognition element                48
  IKZF                IKAROS family zinc finger 5 (Pegasus)                                44
  SP1F                Specificity protein 1, ubiquitous zinc finger transcription factor   40
  EGRF                EGR1, early growth response 1                                        39
  SPZ1                Spermatogenic Zip 1 transcription factor                             32
  EBOX                E-box binding factors                                                29
  AP2F                Transcription factor AP-2, alpha                                     28
  MAZF                Myc associated zinc fingers                                          27
  IKRS                Ikaros 2, potential regulator of lymphocyte differentiation          25
  HESF                Drosophila hairy and enhancer of split homolog 1 (HES-1)             24
  NDPK                Nucleoside diphosphate kinase                                        16
  AP1R                Transcription factor AP-1                                            15

Highlighted in yellow are the transcription factors activated by FSH.

###### 

SP1 binding sites identified in the human IRS-2 promoter region.

Table 2.

  **Detailed matrix information**   **Start position**   **End position**   **Anchor position**   **Strand**   **Core similarity**   **Matrix similarity**   **Sequence**
  --------------------------------- -------------------- ------------------ --------------------- ------------ --------------------- ----------------------- -------------------
  SP1                               −50                  −66                −58                   (−)          1.000                 0.912                   agcatGGGCggcgagcc
  SP1                               −76                  −92                −84                   (−)          1.000                 0.877                   ggcggGGGCtgcggcct
  SP1                               −102                 −118               −110                  (−)          1.000                 0.997                   gggcgGGGCgggggatc
  SP1                               −107                 −123               −115                  (−)          1.000                 0.968                   cggctGGGCggggcggg
  SP1                               −118                 −134               −126                  (−)          1.000                 0.873                   gggcgGGGCcgcggctg
  SP1                               −123                 −139               −131                  (−)          1.000                 0.966                   gcgccGGGCggggccgc
  SP1                               −207                 −223               −215                  (−)          1.000                 0.980                   gggcgGGGCgggccacg
  SP1                               −212                 −228               −220                  (−)          1.000                 0.990                   aagagGGGCggggcggg
  SP1                               −237                 −253               −245                  (−)          1.000                 0.924                   acccaGGGCgggaaaag
  SP1                               −298                 −314               −306                  (+)          1.000                 0.855                   ggccgGGGCcgccccac
  SP1                               −300                 −316               −308                  (−)          1.000                 0.926                   gggtgGGGCggccccgg
  SP1                               −310                 −326               −318                  (−)          1.000                 0.950                   cggccGGGCggggtggg
  SP1                               −321                 −337               −329                  (+)          1.000                 0.888                   cggccGGGCcggggcct
  SP1                               −382                 −398               −390                  (+)          1.000                 1.000                   aagggGGGCggggcggg
  SP1                               −387                 −403               −395                  (+)          1.000                 0.997                   gggcgGGGCgggggcgc
  SP1                               −399                 −415               −407                  (−)          1.000                 0.856                   ggggcGGGCcgcgcgcc
  SP1                               −403                 −419               −411                  (−)          1.000                 0.980                   cgcggGGGCgggccgcg
  SP1                               −479                 −495               −487                  (+)          1.000                 1.000                   cagcgGGGCggggcggc
  SP1                               −484                 −500               −492                  (+)          1.000                 0.919                   gggcgGGGCggccgcgc
  SP1                               −753                 −769               −761                  (−)          1.000                 0.887                   ccgcgGGGCcgagccta
  SP1                               −782                 −798               −790                  (−)          1.000                 0.886                   tcgctGGGCcgggagtc
  SP1                               −808                 −824               −816                  (−)          1.000                 0.921                   ctctcGGGCggcgccgg
  SP1                               −864                 −880               −872                  (−)          1.000                 0.920                   ggcgcGGGCggtggccg
  SP1                               −987                 −1003              −995                  (+)          1.000                 0.927                   tgatcGGGCgggcggcc
  SP1                               −991                 −1007              −999                  (+)          1.000                 0.894                   cgggcGGGCggccgggc
  SP1                               −1025                −1041              −1033                 (−)          1.000                 0.963                   ggcgcGGGCgggggcgg
  SP1                               −1040                −1056              −1048                 (−)          1.000                 0.944                   gcgagGGGCggaggggg

Start/end position, starting/ending position of the consensus binding site in the sequence (relative to IRS-2); core similarity, core consensus sequence (4 highest conserved positions) similarity factor (0--1); matrix similarity; matrix (groups of functionally similar transcription factors) similarity factor (0--1); SP1/GC, stimulating protein 1/GC box elements.
